SEC Filings TLDR

Inspira Technologies Oxy B.H.N. Ltd. announced the appointment of Mr. Mike Hershkovitz as Vice President of Global Sales and Ms. Sivan Matza as a new independent board member. Mr. Hershkovitz brings nearly two decades of experience in healthcare markets, including senior roles at Johnson & Johnson, and will lead the co...

Infosys Limited reported its financial results for the second quarter of fiscal year 2025, ending September 30, 2025. The company achieved a revenue of $5,076 million, marking a 2.9% year-on-year growth and a 2.2% sequential growth in constant currency terms. The operating margin stood at 21.0%, with free cash flow gen...

Immuron Limited announced that its CEO, Steven Lydeamore, will present at the AusBiotech Invest 2025 conference on October 21, 2025, in Melbourne, Australia. The presentation will cover Immuron's proprietary technology platform, which focuses on developing orally delivered targeted polyclonal antibodies for the treatme...

Immuron Limited has submitted an application for the quotation of 1,133,840 ordinary fully paid shares on the Australian Securities Exchange (ASX). The shares were issued on October 20, 2025, as part of a transaction previously announced to the market. The issue price per share is AUD 0.0886, and the shares were purcha...

InterContinental Hotels Group PLC (IHG) announced that Non-Executive Chair Deanna Oppenheimer has taken a short-term leave of absence for medical reasons. During her absence, Senior Independent Non-Executive Director Graham Allan will assume the Chair responsibilities on an interim basis, effective immediately. The com...

ING Groep N.V. reported progress on its €2.0 billion share buyback programme, which was announced on 2 May 2025. During the week of 13 October 2025 to 17 October 2025, the company repurchased 4,381,000 shares at an average price of €20.91, totaling €91,614,268.60. To date, ING has repurchased 96,504,891 shares at an av...

Immutep Limited announced two poster presentations at the European Society for Medical Oncology (ESMO) Congress 2025, focusing on changing the treatment landscape in first-line non-small cell lung cancer (1L NSCLC). The presentations highlighted the novel combination of eftilagimod alfa (efti) with KEYTRUDA® (pembroliz...

Immutep Limited announced positive results from the EFTISARC-NEO Phase II trial, which evaluated the neoadjuvant use of eftilagimod alfa (efti) in combination with radiotherapy and pembrolizumab for resectable soft tissue sarcoma (STS). The trial met its primary endpoint, achieving a median 51.5% tumour hyalinization/f...

High Tide Inc. has announced an increase in its long-term targets for its Cabana Club loyalty program and Canna Cabana retail locations. The company now aims to reach 3 million Cabana Club members and expand to 350 Canna Cabana stores across Canada. This announcement comes as the company celebrates the four-year annive...

HUTCHMED (China) Limited announced the vesting of non-performance based awards granted under its Long Term Incentive Plan (LTIP) on October 20, 2021. The awards were vested on October 20, 2025, for Dr Dan Eldar, Ms Edith Shih, and Professor Tony Mok, who are non-executive directors and an independent non-executive dire...

HSBC Holdings plc announced the purchase of 800 of its ordinary shares for cancellation on 21 October 2025. The shares were bought at a price of HK$102.1000 per share. This transaction is part of the buy-back program announced on 31 July 2025. Since the commencement of the buy-back, the company has repurchased 226,044,...

GeoPark Limited, a leading independent energy company, has outlined its long-term strategic plan and provided an operational update for the third quarter of 2025. The strategic plan focuses on disciplined growth, leveraging its strong foundation in Colombia and new opportunities in Argentina's Vaca Muerta formation. Th...

GSK plc announced that the European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the approval of Shingrix in a prefilled syringe. This new presentation will simplify the vaccine administration process for healthcare professionals by removing the need to recon...

GSK plc announced the purchase of 220,000 of its ordinary shares on 20 October 2025 as part of its existing buyback program. The shares were bought through BNP Paribas SA, with prices ranging from 1,615.00p to 1,637.00p per share. The volume-weighted average price paid was 1,628.13p. Following this transaction, GSK plc...

GSK plc and Spero Therapeutics announced positive results from the pivotal Phase III PIVOT-PO trial for tebipenem HBr, an investigational oral treatment for complicated urinary tract infections (cUTIs), including pyelonephritis. The trial demonstrated non-inferiority of tebipenem HBr compared to intravenous imipenem-ci...

Galapagos NV has announced its intention to wind down its cell therapy business following a comprehensive strategic review. The decision was made after considering various alternatives, including a potential divestiture, but no viable proposals were received. The company plans to reallocate its resources to focus on bu...

Ferrari N.V. announced that it will release its financial results for the third quarter of 2025 on November 4, 2025. The company will host a live audio webcast and conference call at 2:00 p.m. GMT / 3:00 p.m. CET / 9:00 a.m. EST on the same day. Details for accessing the presentation will be available in the Investors ...

Fury Gold Mines Limited has announced the commencement of a 10,000-metre fall/winter drilling program at its wholly owned Eau Claire Gold Project in Quebec. The program, based on recommendations from the recent Eau Claire PEA, aims to focus on resource growth and enhancing the mine plan. Two drill rigs are currently ac...

Enlight Renewable Energy Ltd. will release its financial results for the third quarter ended September 30, 2025, on November 12, 2025, prior to the opening of the Tel Aviv Stock Exchange. The company will host two conference calls to review the financial results and business outlook—one in English and one in Hebrew. Th...

On October 15, 2025, Earlyworks Co., Ltd. completed a private placement offering, selling pre-funded warrants and ordinary warrants to purchase up to 2,403,847 American Depositary Shares (ADSs) for a total purchase price of $5,000,001.76. The pre-funded warrants were immediately exercisable, while the ordinary warrants...

Equinor ASA has completed the third tranche of its 2025 share buy-back programme, purchasing a total of 1,129,635 own shares from 13 October to 17 October 2025 at an average price of NOK 235.3736 per share. The total transaction value for this period was NOK 265,886,226.79. Including previously disclosed buy-backs unde...

Embraer S.A. reported a record backlog of US$31.3 billion in the third quarter of 2025, marking an unprecedented high for the company. The backlog was driven by strong performance across all business units, with Commercial Aviation reaching a 9-year high of US$15.2 billion, supported by a 2.7x book-to-bill ratio. Execu...

Digi Power X Inc. (Nasdaq: DGXX / TSXV: DGX) announced strategic initiatives, including the expansion of its AI data center capacity with the addition of five new ARMS-200 GPU modules, scheduled to come online at its Columbiana, Alabama facility in March 2026. This expansion will increase the company's total GPU capaci...

DRDGOLD Limited, a foreign private issuer, reported a securities transaction by its Chief Financial Officer, Riaan Davel, in compliance with the JSE Limited Listings Requirements. The transaction involved the on-market sale of 137,067 ordinary shares of DRDGOLD on October 17, 2025. The shares were sold at various price...

Dr. Reddy’s Laboratories Limited has received the Establishment Inspection Report (EIR) from the United States Food & Drug Administration (USFDA) regarding the inspection conducted at their formulations manufacturing facility FTO 11 in Srikakulam, Andhra Pradesh, India. The inspection, which took place earlier, has bee...